The exosome diagnostic and therapeutic market is projected to grow at a CAGR of 9.1% from 2024 to 2034. Market valuation will increase from USD 88.56 million in 2024 to USD 211.6 million by 2034.

Sanford C. Bernstein upgraded shares of Thermo Fisher Scientific (NYSE:TMO – Free Report) from a market perform rating to an ...

All these years later, Fisher can still remember vividly just how much Bryant et al. obsessed over Boston having beaten them in the 2008 NBA Finals.

From San Diego to Washington, D.C., Oliver Cottrell’s invention won prestigious awards in the past year. And now he has a new ...

Shares of Thermo Fisher Scientific Inc. TMO shed 0.48% to $542.31 Friday, on what proved to be an all-around poor trading ...

Browse 194 market data Tables and 45 Figures spread through 226 Pages and in-depth TOC on "Slide Stainer Market by Product ...

Eli Lilly has been operating a global capability center (GCC) in Bengaluru, India. | For nearly a decade, Eli Lilly has been ...

LGC has announced that Joydeep Goswami is joining its Board of Directors and Executive Leadership Team (ELT) as President and ...

Grossing Application, while Consumer Genomics is Predicted to Grow at the Highest CAGR, Owing to the Growing Interest in Personal Genetic Testing for Ancestry, Health Risks, and Traits Global ...

Bernstein upgraded Thermo Fisher (TMO) to Outperform from Market Perform with a $630 price target While the setup in 2025 for U.S. Life ...

In a report released today, Eve Burstein from Bernstein maintained a Buy rating on Thermo Fisher (TMO – Research Report), with a price target ...